곽진 방대본 환자관리팀장은 "두 명 모두 발열, 발진, 충혈, 복통 등 가와사키병 범위에 들어가는 임상 양상을 보였다"며 "면역글로불린 치료를 통해 증상이 많이 호전됐다"고 했다.
Kwak Jin, head of the patient care team at Central Disease Control Headquarters, said, "Both showed clinical signs that fall within the scope of Kawasaki disease such as fever, rash, bloodshot wounds, and abdominal pain. The symptoms have improved a lot through immunoglobulin treatment."